[Deaths, Burned Clinics - What’s Different About Ebola’s 2026 Return?](https://wbbsec.com/opinions-and-features/deaths-burned-clinics-whats-different-about-ebolas-2026-return-published-in-forbes/)
[Deaths, Burned Clinics - What’s Different About Ebola’s 2026 Return?](https://wbbsec.com/opinions-and-features/deaths-burned-clinics-whats-different-about-ebolas-2026-return-published-in-forbes/)
  •   (858) 592-9901
  •   [email protected]
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute
WBB Securities, LLCWBB Securities, LLC
  • Our Firm
    • The Team
    • Advisor Services
      • About the Broker-Dealer & RIA
  • Investment Banking
    • Life Sciences Sectors
    • M&A and Strategic Advisory
    • Institutional Sales
    • Equity Capital Markets
  • Research
    • Research Samples
  • News
    • Press Releases
    • Opinions & Features
    • SARS-CoV-2
    • Video Presentations
  • Asset Management
  • WBB Research Institute

Press Releases

WBB Securities President Steve Brozak Gives A SARS-CoV-2 Presentation Followed By A Q&A Session At Columbia University.

By:WBB SecuritiesPosted: May 19th, 2021In: Press Releases

Steve Brozak, the Managing Partner and President of WBB Securities gave a comprehensive presentation about SARS-CoV-2 at Columbia University...

Read More about WBB Securities President Steve Brozak Gives A SARS-CoV-2 Presentation Followed By A Q&A Session At Columbia University.

WBB Securities Sponsors Demy-Colton Virtual Salon “Sepsis: A Critical Healthcare Burden Needing Rapid Diagnoses to Improve Patient Outcomes”

By:WBB SecuritiesPosted: Mar 25th, 2021In: Press Releases

WBB Securities, sponsored a Demy-Colton Virtual Salon focused on the critical need for point-of-care...

Read More about WBB Securities Sponsors Demy-Colton Virtual Salon “Sepsis: A Critical Healthcare Burden Needing Rapid Diagnoses to Improve Patient Outcomes”

WBB Securities President Steve Brozak will moderate a Live Forum at Biotech Showcase today.

By:WBB SecuritiesPosted: Jan 6th, 2021In: Press Releases

Steve Brozak, Managing Partner and President of WBB Securities, LLC will moderate a live forum at Biotech Showcase on January 6, 2021.

Read More about WBB Securities President Steve Brozak will moderate a Live Forum at Biotech Showcase today.

WBB Securities Acts As Co-Manager In a $85 Million Public Offering, Pre-Funded Warrants and Warrants For SCYNEXIS, Inc.

By:WBB SecuritiesPosted: Dec 22nd, 2020In: Press Releases

WBB Securities Acts As Co-Manager In a $85 Million Public Offering...

Read More about WBB Securities Acts As Co-Manager In a $85 Million Public Offering, Pre-Funded Warrants and Warrants For SCYNEXIS, Inc.

WBB Securities Acts As Co-Manager In a $15.0 Million Public Offering For CohBar Inc.

By:WBB SecuritiesPosted: Aug 28th, 2020In: Press Releases

WBB Securities acted as co-manager for a public offering of CohBar Inc. on August 28, 2020...

Read More about WBB Securities Acts As Co-Manager In a $15.0 Million Public Offering For CohBar Inc.

WBB Securities Acts As Co-Manager In a $115.06 Million Public Offering For Omeros, Corporation.

By:WBB SecuritiesPosted: Aug 12th, 2020In: Press Releases

WBB Securities acted as co-manager for a public offering of Omeros Corporation on August 11, 2020...

Read More about WBB Securities Acts As Co-Manager In a $115.06 Million Public Offering For Omeros, Corporation.

WBB Securities President Steve Brozak Appeared as an Invited Speaker at The Sachs Associates Digital Novel Coronavirus Investment Forum

By:WBB SecuritiesPosted: Jul 9th, 2020In: Press Releases

Steve Brozak, President of WBB Securities appeared as an invited speaker at the Sachs Associates...

Read More about WBB Securities President Steve Brozak Appeared as an Invited Speaker at The Sachs Associates Digital Novel Coronavirus Investment Forum

WBB Securities Acts As Co-Manager In $57.6 Million Financing For Athersys, Inc.

By:WBB SecuritiesPosted: Apr 20th, 2020In: Press Releases

WBB Securities acted as co-manager for a transaction on April 16 for Athersys, Inc., Gross proceeds...

Read More about WBB Securities Acts As Co-Manager In $57.6 Million Financing For Athersys, Inc.

WBB Securities Acts As Co-Manager In $35 Million Follow-On Financing For Scynexis, Inc.

By:WBB SecuritiesPosted: Dec 12th, 2019In: Press Releases

WBB Securities acted as co-manager to a transaction for Scynexis, Inc., is a biotechnology company primarily focused on drugs to treat infectious diseases.

Read More about WBB Securities Acts As Co-Manager In $35 Million Follow-On Financing For Scynexis, Inc.

WBB Securities Sponsors BioCentury’s Annual NewsMakers Conference

By:WBB SecuritiesPosted: Sep 6th, 2019In: Press Releases

Executive Teams of Emerging Biotech Companies Present to Investor Community For Immediate Release September 6, 2019 SAN DIEGO, CA – WBB Securities is a sponsor of this year’s NewsMakers in the Biotech Industry conference.  The Newsmakers[...]

Read More about WBB Securities Sponsors BioCentury’s Annual NewsMakers Conference
Load More

Recent News

  • Deaths, Burned Clinics—What’s Different About Ebola’s 2026 Return? – Published in Forbes May 25, 2026
  • 5 Urgent Questions After The WHO Emergency Hantavirus Meeting – Published in Forbes May 15, 2026
  • Our Mental Health Crisis: RFK Jr. Faces Psychiatric Over-Prescribing – Published in Forbes May 6, 2026
  • WBB Securities President Dr. Steve Brozak to Moderate ARPA-H Panel at Biotech Showcase 2026 on Federal Investment in Biotech Innovation January 12, 2026
  • WBB Securities Initiates Coverage of Turn Therapeutics (Nasdaq: TTRX) January 12, 2026

20 Commerce Dr.
Ste. 135
Cranford, NJ 07016

3111 Camino Del Rio N.
Ste. 400
San Diego, CA 92108

Copyright © 2026 WBB Securities, LLC. All Rights Reserved. Member FINRA/SIPC, BrokerCheck

  • Form CRS
  • Disclosures
  • Privacy Policy
Menu Bottom